The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pathologic discordance in sarcomas: Prospective comparison of external and sarcoma center pathologic diagnosis.
 
Mark A. Eckardt
No Relationships to Disclose
 
Danielle S. Graham
No Relationships to Disclose
 
Arun S. Singh
Stock and Other Ownership Interests - AntiCancer; Certis Oncology Solutions
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Lilly
Speakers' Bureau - Eisai; Lilly; Novartis
Research Funding - Bristol-Myers Squibb (Inst); Lilly (Inst); Nanocarrier (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo; Deciphera; Eisai; Lilly; Novartis
Other Relationship - Certis Oncology Solutions
 
Bartosz Chmielowski
Consulting or Advisory Role - Array BioPharma; Biothera; Bristol-Myers Squibb; Compugen; Genentech/Roche; HUYA Bioscience International; Iovance Biotherapeutics; Janssen; Merck; Novartis; Regeneron
Speakers' Bureau - Genentech/Roche; Janssen Oncology
Research Funding - Advenchen Laboratories (Inst); Aeglea Biotherapeutics (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Biothera (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); GlaxoSmithKline (Inst); Idera (Inst); Immunocore (Inst); Incyte (Inst); Infinity Pharmaceuticals (Inst); Karyopharm Therapeutics (Inst); Lilly/ImClone (Inst); Macrogenics (Inst); Merck (Inst); Neon Therapeutics (Inst); Rgenix (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - Array BioPharma; Biothera; Bristol-Myers Squibb; Compugen; Genentech/Roche; HUYA Bioscience International; Iovance Biotherapeutics; Janssen; Regeneron
 
Noah Federman
Stock and Other Ownership Interests - Reata Pharmaceuticals
Consulting or Advisory Role - Bayer; Loxo; Zelda Therapeutics
Speakers' Bureau - Bayer
 
Anusha Kalbasi
No Relationships to Disclose
 
Nicholas M. Bernthal
Honoraria - Daiichi Sankyo
Consulting or Advisory Role - Bonesupport; Onkos Surgical
Research Funding - Onkos Surgical
 
Susan V. Bukata
Leadership - National Osteoporosis Foundation; Orthopedic Research Society
Consulting or Advisory Role - Amgen; Lilly; Radius Health
 
Francis J. Hornicek
Stock and Other Ownership Interests - Bone Solutions
Consulting or Advisory Role - Bone Solutions; Globus; Stryker
Research Funding - Stryker
Patents, Royalties, Other Intellectual Property - Biome Al, Inc; Biomet; Stryker
Travel, Accommodations, Expenses - Stryker
 
Jane Yanagawa
No Relationships to Disclose
 
Benjamin D. Levine
No Relationships to Disclose
 
Kambiz Motamedi
No Relationships to Disclose
 
Leanne L. Seeger
Consulting or Advisory Role - Amgen
 
Jeffrey J. Eckardt
No Relationships to Disclose
 
Frederick R. Eilber
No Relationships to Disclose
 
Sarah M. Dry
Other Relationship - College of American Pathologists
 
Scott D. Nelson
No Relationships to Disclose
 
Frederick C. Eilber
Stock and Other Ownership Interests - AntiCancer-PDOX; Certis Oncology Solutions